From New Mechanisms to New Standards of Care
Latest News
News / 11 Dec 2018
Financial Results for the Third Quarter and Nine Months Ended 31 October 2018 and Operational Progress
News / 12 Nov 2018
Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness Week
News / 01 Nov 2018
Summit Recognises C. difficile Awareness Month
We are building a very different antibiotics company that focuses on bringing innovation to antibiotic development. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
Chief Executive Officer
For Investors
Visit our dedicated section for investors that contains the latest available financial and regulatory information
Latest Event
Watch our webcast presentation at the Rodman & Renshaw Global Investment Conference
Our Discuva Platform
Our technology platform is at the heart of our research to develop new mechanism antibiotics